SCHEMBL8901941

SCHEMBL8901941

C1=CCCC(N2CC=CCC2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15323355 0.92
SCHEMBL22072994 0.88 KDM4E (0.35)
SCHEMBL22073002 0.88 KDM4E (0.32)
SCHEMBL22073010 0.86 KDM4E (0.37)
SCHEMBL2974735 0.82 KMT2A (0.33)
SCHEMBL2968855 0.76 L3MBTL3 (0.41)
SCHEMBL19313016 0.76 KDM4E (0.39)
SCHEMBL27676503 0.73 POLB (0.32)
SCHEMBL19312856 0.72 L3MBTL3 (0.46)
SCHEMBL19121643 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5688805-A INHIBITORS OF TUMOR NECROSIS FACTOR-A, TREATMENT OF SEPTIC SHOCK, ANTIINFLAMMATORY, ANTIALLERGEN SCHERING CORPORATION (US) 1997-11-18 US disclosed